Ankylosing spondylitis, HLA-B27 positivity and the need for biologic therapies

Joint Bone Spine

Volumn 74, Issue 2, 2007, Pages 140-143

  Freeston, Jane ^a   Barkham, Nick ^a   Hensor, Elizabeth ^a   Emery, Paul ^a   Fraser, Alexander ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Ankylosing spondylitis; Biological therapy; HLA antigens

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; QUALITY OF LIFE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; BIOLOGICAL MARKERS; BIOLOGICAL THERAPY; COHORT STUDIES; FEMALE; GREAT BRITAIN; HLA-B27 ANTIGEN; HUMANS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; STEROIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247097146     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2006.11.003     Document Type: Article

References (21)

1. Brewerton D., Hart F., Nicholls A., Caffrey M., James D., and Sturrock R. Ankylosing spondylitis and HLA-B27. Lancet 1 (1973) 904-907
2. Sheehan N.J. The ramifications of HLA-B27. J R Soc Med 97 (2004) 10-14
3. Linssen A. B27+ disease versus B27- disease. Scand J Rheumatol Suppl 87 (1990) 111-118 discussion 118-9
4. Barkham N., Kong K., Tennant A., Fraser A., Hensor E., Keenan A., et al. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis. Rheumatology 44 (2005) 1277-1281
5. Khan M., Kushner I., and Braun W. Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum 20 (1977) 909-912
6. Feldtkeller E.K.M., van der Heijde D., van der Linden S., and Braun J. Age at disease onset and diagnosis delay in HLA B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23 (2003) 61-66
7. Linssen A., Rothova A., Valkenburg H.A., Dekker-Saeys A.J., Luyendijk L., Kijlstra A., et al. The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci 32 (1991) 2568-2578
8. Bergfeldt L., Insulander P., Lindblom D., Moller E., and Edhag O. HLA-B27: an important genetic risk factor for lone aortic regurgitation and severe conduction system abnormalities. Am J Med 85 (1988) 12-18
9. Hillerdal G. Ankylosing spondylitis lung disease - an underdiagnosed entity?. Eur J Respir Dis 64 (1983) 437-441
10. Rudwaleit M., Listing J., Brandt J., Braun J., and Sieper J. Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 63 (2004) 665-670
11. Altin R., Ozdolap S., Savranlar A., Sarikaya S., Tor M., Kart L., et al. Comparison of early and late pleuropulmonary findings of ankylosing spondylitis by high-resolution computed tomography and effects on patients' daily life. Clin Rheumatol 24 (2005) 22-28
12. Jeandel P., Bonnet D., Chouc P.Y., Molinier S., Raphenon G., Martet G., et al. Demonstration of subclinical pulmonary alveolitis in spondyloarthropathies. Rev Rhum Ed Fr 61 (1994) 301-309
13. Turkcapar N., Toruner M., Soykan I., Aydintug O.T., Cetinkaya H., Duzgun N., et al. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int 26 (2006) 663-668
14. Palm O., Moum B., Ongre A., and Gran J.T. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol 29 (2002) 511-515
15. Mielants H., Veys E.M., Goemaere S., Goethals K., Cuvelier C., and De Vos M. Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. J Rheumatol 18 (1991) 1542-1551
16. Moller P., Vinje O., and Berg K. HLA antigens, psoriasis and acute anterior uveitis in Bechterew's syndrome (ankylosing spondylitis). Clin Genet 21 (1982) 215-221
17. Zeidler H., Kuipers J., and Kohler L. Chlamydia-induced arthritis. Curr Opin Rheumatol 16 (2004) 380-392
18. Perez-Guijo V., Santos-Lacomba M., Sanchez-Hernandez M., Castro-Villegas Mdel C., Gallardo-Galera J.M., and Collantes-Estevez E. Tumour necrosis factor-alpha levels in aqueous humour and serum from patients with uveitis: the involvement of HLA-B27. Curr Med Res Opin 20 (2004) 155-157
19. Hohler T., Schaper T., Schneider P.M., Meyer zum Buschenfelde K.H., and Marker-Hermann E. Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 41 (1998) 1489-1492
20. Rudwaleit M., Siegert S., Yin Z., Eick J., Thiel A., Radbruch A., et al. Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 60 (2001) 36-42
21. Reveille J., and Arnett F. Spondyloarthritis: update on pathogenesis and management. Am J Med 118 (2005) 592-603